nandrolone decanoate has been researched along with Acquired Immune Deficiency Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allen, BJ; Bodsworth, NJ; Finlayson, R; Furner, VL; Gold, J; High, HA; Li, Y; Michelmore, H; Oliver, CJ | 1 |
| Batterham, M; Gold, J | 1 |
2 trial(s) available for nandrolone decanoate and Acquired Immune Deficiency Syndrome
| Article | Year |
|---|---|
Safety and efficacy of nandrolone decanoate for treatment of wasting in patients with HIV infection.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anthropometry; Body Mass Index; Body Weight; CD4 Lymphocyte Count; Dietary Fats; HIV Infections; HIV Wasting Syndrome; Humans; Male; Middle Aged; Nandrolone; Nandrolone Decanoate; Nitrogen; Quality of Life; Surveys and Questionnaires | 1996 |
Nandrolone decanoate; use in HIV-associated lipodystrophy syndrome: a pilot study.
Topics: Acquired Immunodeficiency Syndrome; Anabolic Agents; Humans; Lipodystrophy; Nandrolone; Nandrolone Decanoate; Pilot Projects | 1999 |